Minnesota · Care fieldnotes
Questions when a medicine is proposed
An exact name makes the conversation easier. Have your care professional write down the medicine’s name, its form as a pill or shot, and the health problem it would address.
If the medicine is made to order
What is different about this medicine compared with the ready-made one? Why does that change matter for my health? Which pharmacy makes it?
A compounded medicine is made or mixed for a patient.
As of September 26, 2026, it lacks product approval from the federal drug agency, the FDA. Ask what evidence supports the proposed care without treating approval of another product as approval of this one.
What will the label say? Whom can I ask about anything on it that I do not understand?
If semaglutide or tirzepatide comes up
As checked September 26, 2026, approved products include Ozempic and Wegovy with semaglutide, and Mounjaro and Zepbound with tirzepatide.
As of September 26, 2026, FDA records did not list semaglutide injection or tirzepatide in national shortage. A local empty shelf is a different issue.
If a pharmacy-made version is proposed, ask: “Why can’t the ready-made medicine meet my need? What change would help me, and how does it meet the legal rules?” For example, avoiding an ingredient you are allergic to can be a reason for a change.
If the reason given is a shortage, ask for the current FDA shortage record. An empty shelf at your pharmacy is a local supply problem, distinct from a shortage across the country.
As of September 26, 2026, the FDA says semaglutide sodium and semaglutide acetate differ from the ingredient in approved medicines. It says it knows of no legal way to use these ingredients in compounded medicines. This is a warning, not permission to use them.
These are different chemical versions, sometimes called “salt forms”. Ask for the full ingredient name. If “sodium” or “acetate” follows “semaglutide” on your label, ask the prescriber and pharmacist to explain it before you use the medicine.
Ask about the plan beyond a prescription
What will we look for at follow-up? What concerns would mean I need to contact the care team? What happens if we decide this is not the right option?
Ask about your other medicines and any pregnancy plans during the visit. Keep the answer tied to the exact product being discussed.
Keep the source in reach
Source note
The FDA distinguishes a national shortage listing from local supply problems.
Read the FDA’s shortage and compounding updatesSource note
The FDA explains why sodium and acetate forms are different from the approved ingredient.
Read the FDA’s explanation of semaglutide saltsBefore you move on
A complete answer explains the medicine, why it is being offered, the pharmacy, and how your care will be checked after the prescription.
Follow the medicine to the pharmacy check